The AI Cure for German Paperwork

Doctolib debuts an AI-powered practice platform in Germany, promising to slash administrative workloads by ten hours every week

30 Nov 2025

Doctolib, Europe's largest digital health booking service, has expanded into full practice management software in Germany, bundling appointment scheduling, clinical documentation, billing and AI-driven telephone handling into a single system. Its autumn 2025 rollout targets general practitioners, paediatricians and gynaecologists.

At the platform's core sit three AI tools. A virtual assistant handles inbound calls and routes bookings continuously. A consultation tool transcribes patient visits in real time, producing structured clinical notes with diagnostic coding suggestions. Completing the suite, a billing module recommends appropriate fee codes and flags errors automatically, addressing what practices frequently cite as their most time-consuming administrative burden.

Practices, Doctolib estimates, can recover up to ten hours of administrative time each week.

Years of quiet groundwork underpin the move. By building its position in Germany through its scheduling platform, Doctolib has assembled a base of more than 120,000 healthcare professionals in the country. That reach gives it a direct route to displace older practice management providers while increasing revenue per customer. Germany contributes roughly a fifth of annual recurring revenue, and new German revenues grew sharply in the first quarter of 2025, according to analysts tracking the group.

Expansion to further specialties is planned for 2026, with France and Italy expected to follow as subsequent markets.
Regulatory exposure remains a live concern. Data protection advocates have raised persistent questions about how Doctolib processes sensitive patient information, and Berlin's data protection authority has received a series of complaints about transparency in its data practices. Navigating those pressures while scaling an increasingly data-intensive AI product will be a central test of the company's ambitions. With a potential IPO window cited for late 2026, demonstrating both platform depth and improving profitability has become urgent.